We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Tanios Bekaii-Saab

Tanios S Bekaii-Saab MD, FACP

Professor , Mayo Clinic College of Medicine and Science, Program Leader , Gastrointestinal Cancer, Mayo Clinic Cancer Center, Vice-Chair and Section Lead, Division of Medical Oncology, Medical Director , Cancer Clinical Research Office (CCRO), Consultant , Mayo Clinic AZ , USA

Recent Contributions to PracticeUpdate:

  1. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

Most Read This Week

Recently Updated